You are using an older browser version. Please use a supported version for the best MSN experience.

Karuna CEO says he doesn't expect company's KarXT schizophrenia drug to lose its efficacy over time

CNBC's Jim Cramer spoke with Karuna Therapeutics CEO Steve Paul on Wednesday's episode of "Mad Money."
image beaconimage beaconimage beacon